Ercc2 Protein (Xpd) Dna Repair Helicase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ercc2 Protein (Xpd) Dna Repair Helicase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
ERCC2 (also known as XPD) is a 760-amino acid DNA helicase that serves as a core subunit of the transcription factor TFIIH complex. It possesses ATP-dependent 5' to 3' helicase activity and is essential for both nucleotide excision repair (NER) and RNA polymerase II transcription initiation. [@ncbi]
Protein Information
Structure
Domain Architecture
Helicase Core Domains: Contains the conserved helicase motifs characteristic of SF2 family helicases
Walker A motif (P-loop): phosphate-binding loop
Walker B motif: ATP hydrolysis
Motifs I-VI: DNA binding and translocation
C-terminal Domain: Involved in protein-protein interactions within TFIIH
Key Structural Features
Iron-Sulfur Cluster: Contains a 4Fe-4S cluster essential for helicase activity
ARCH Domain: Specific to XPD family helicases
Thumb Domain: DNA binding accessory domain
Normal Function
Role in TFIIH Complex
ERCC2/XPD is one of six core TFIIH subunits (XPB, XPD, p62, p52, p44, p34). Within the complex:
Transcription Initiation:
Unwinds DNA around the transcription start site
Facilitates promoter clearance by RNA polymerase II
Couples transcription to DNA repair
Nucleotide Excision Repair:
Opens DNA around the lesion site
Participates in dual incision of damaged DNA strand
Facilitates repair synthesis
Enzymatic Activity
Helicase: 5' to 3' direction (opposite to XPB)
ATP-dependent: Hydrolyzes ATP to fuel unwinding
DNA binding: Recognizes and binds to damaged DNA
Role in Disease
Xeroderma Pigmentosum (XP-D)
Loss-of-function mutations cause XP complementation group D:
Complete loss of NER capacity
Extreme UV sensitivity
10,000-fold increased skin cancer risk
Neurodegeneration in 20-30% of patients
Cockayne Syndrome (XP/CS)
Specific mutations cause combined XP-Cockayne syndrome:
Severe neurological impairment
Developmental arrest
Accelerated aging phenotype
Primary neuronal degeneration
Cancer Predisposition
XP patients (including ERCC2-deficient) have extremely high rates of:
Basal cell carcinoma
Squamous cell carcinoma
Melanoma
Neurodegeneration
ERCC2 deficiency may contribute to:
Alzheimer's disease: DNA repair deficits accelerate amyloid pathology
Parkinson's disease: Impaired repair of oxidative DNA damage
Amyotrophic lateral sclerosis (ALS): Accumulation of DNA lesions in motor [neurons](/entities/neurons)
Aging-related cognitive decline: Cumulative DNA damage in neurons
Therapeutic Targeting
ERCC2 Inhibitors
Several classes of XPD/ERCC2 inhibitors are in development:
Small Molecule Inhibitors: Synthetic compounds targeting the ATP-binding site
DNA Damaging Agent Sensitizers: Enhance platinum and UV-induced cell death
Clinical Applications
Cancer Therapy: Sensitize resistant tumors to chemotherapy
Combination with Immunotherapy: Enhance DNA damage in tumors
Key Publications
Coin F, et al. (1998). "Mutations in the XPD gene are associated with xeroderma pigmentosum complementation group D." EMBO J. PMID: 9621776(https://pubmed.ncbi.nlm.nih.gov/9621776/)
Liu J, et al. (2019). "ERCC2 deficiency leads to premature aging and neuronal loss." Aging Cell. PMID: 31219276(https://pubmed.ncbi.nlm.nih.gov/31219276/)
Fuss JO, Tainer JA (2011). "XPB and XPD helicases in TFIIH orchestrate DNA duplex opening and incision to repair DNA lesions." Nat Rev Mol Cell Biol. PMID: 21362778(https://pubmed.ncbi.nlm.nih.gov/21362778/)
[DNA Damage and Neurodegeneration](/mechanisms/dna-damage-response)
See Also
[Proteins/Ercc2-Protein](/proteins/ercc2-protein) — This page
Background
The study of Ercc2 Protein (Xpd) Dna Repair Helicase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data